Authors
Latest:
Secondary Prevention Strategies for Nonmelanoma Skin CancerIn this article, we review the published literature and evaluate secondary prevention strategies for nonmelanoma skin cancer. We also explore investigational therapies proposed for chemoprevention of nonmelanoma skin cancers.
Latest:
Secondary Prevention Strategies for Nonmelanoma Skin CancerIn this article, we review the published literature and evaluate secondary prevention strategies for nonmelanoma skin cancer. We also explore investigational therapies proposed for chemoprevention of nonmelanoma skin cancers.
Latest:
Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune DiseaseIn this article, we detail the experience with immune checkpoint inhibitors in patients with autoimmune disease.
Latest:
Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid MalignanciesIn this second part of our two-part review, we discuss the use of mutation profiling in the diagnosis, prognosis, and treatment of patients with myeloproliferative neoplasms and other myeloid diseases.
Latest:
Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid MalignanciesIn this second part of our two-part review, we discuss the use of mutation profiling in the diagnosis, prognosis, and treatment of patients with myeloproliferative neoplasms and other myeloid diseases.
Latest:
Implications of Mutation Profiling in Myeloid Malignancies-PART 2: Myeloproliferative Neoplasms and Other Myeloid MalignanciesIn this second part of our two-part review, we discuss the use of mutation profiling in the diagnosis, prognosis, and treatment of patients with myeloproliferative neoplasms and other myeloid diseases.
Latest:
Clinical Pearls for Community Oncologists Treating MyelofibrosisThe panel closes their discussion on myelofibrosis treatment updates by sharing clinical pearls for community oncologists.
Latest:
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung CancerIn this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
Latest:
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung CancerIn this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
Latest:
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung CancerIn this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
Latest:
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung CancerIn this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
Latest:
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung CancerIn this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
Latest:
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung CancerIn this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
Latest:
Uncovering Epigenetic Targets in CancerDr. Stephen Baylin discusses his 2018 AACR meeting presentation on SU2C research into using epigenetic therapy to boost immune checkpoint therapy.
Latest:
Systemic Treatment Options for Brain Metastases from Non–Small-Cell Lung CancerIn this review, we discuss recent clinical investigations that highlight the effects of novel compounds targeting EGFR, ALK, and other receptor oncogenes, as well as the promise of immunotherapy in lung cancer CNS disease.
Latest:
Non-Clear Cell RCC: Key Learnings and Future Research DirectionsThe panel discusses key learnings from recent studies in non-clear cell RCC subtypes and the need to better understand disease biology to develop optimized, histology-specific therapies rather than extrapolating clear cell treatment approaches.
Latest:
OncoMasTR Assay May Help Some Breast Cancer Patients Avoid ChemoIn this video, Dr. Arman Rahman explains how the OncoMasTR protein assay may help women with breast cancer avoid unnecessary chemotherapy.
Latest:
Inhibit CXCR4 to Treat CRC and Pancreatic CancerIn this video, Dr. Douglas Fearon outlines ways that inhibiting CXCR4 may provoke an immune response to treat pancreatic and colorectal cancer.
Latest:
The 411 on TCGA: Share ‘Omics’ Data for Precision OncologyIn this video, Dr. Jean Zenklusen describes an NCI tool that enables researchers, clinicians, and patients to access an array of cancer-related data.
Latest:
Oncology Peer Review On-The-Go: Debra Patt, MD, PhD, MBA, on Telehealth in Cancer CareCancerNetwork® spoke with Debra Patt, MD, PhD, MBA, about the role of telehealth in caring for patients with cancer during the COVID-19 pandemic and beyond.
Latest:
Forecasting PARP Inhibitor Resistance in Breast Cancer PatientsIn this video, Dr. Elizabeth Swisher reviews the use of PARP inhibitors in breast cancer, and the importance of understanding how resistance to these agents develops.
Latest:
Xenograft Platform Could Lead to Mouse-Based Clinical TrialsIn this video, Dr. Edison Liu describes a novel patient-derived xenograft platform that might enable development of a mouse-based clinical trials program.
Latest:
ctDNA Increase May Predict Regorafenib Response in Advanced CRCIn this video, Pashalina Kehagias discusses how an early increase in ctDNA may predict a poor response to regorafenib in advanced CRC.
Latest:
Small-Molecule TKIs: Potential Benefit in Multiple MalignanciesIn this video, Dr. Brian Schwartz highlights several small-molecule TKIs in development with the potential to help patients with several malignancies.
Latest:
Breast Cancer and African AncestryIn this video, Dr. Melissa Davis explains how African ancestry may play a role in breast cancer, and ways that genetics might be used to help guide treatment.
Latest:
POINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate CancerChemotherapy is the best option for the initial management of metastatic prostate cancer.
Latest:
COUNTERPOINT: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate CancerAbiraterone has become the first-choice treatment for men with metastatic prostate cancer.
Latest:
Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast CancerHere, we discuss how to improve adherence to endocrine therapy in women with HR-positive breast cancer, as well as the side effects and the reasons for discontinuation.
Latest:
Immunizing Cancer Patients: Which Patients? Which Vaccines? When to Give?This article provides guidance to oncology clinicians on vaccine recommendations and safety of use in their patients.
Latest:
Robert Chapkin on Relationships Between the Gut Microbiome, Diet, and Colorectal CancerIn this Q&A, we discuss the research into the relationships between gut microbiota, diet, and colorectal cancer.
